Device
CMRI
CMRI is a medical device with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Phase Distribution
Ph phase_4
1
20%
Ph not_applicable
1
20%
Ph phase_2
1
20%
Ph phase_1
1
20%
Phase Distribution
1
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
80.0%
4 of 5 finished
Non-Completion Rate
20.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Terminated(1)
Detailed Status
Completed4
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (25.0%)
Phase 21 (25.0%)
Phase 41 (25.0%)
N/A1 (25.0%)
Trials by Status
withdrawn120%
completed480%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_2
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
NCT01086540
completednot_applicable
Cardiac (CMRI) Assessment of Acromegaly
NCT02948322
completed
Virtual Reality for Neglect Diagnostics
NCT01399073
completedphase_4
A Pilot Investigation Detecting Cryoablation Scar by 3D Late Gadolinium Enhancement
NCT02875730
withdrawnphase_1
Stem Cell Therapy as Adjunct to Revascularization
NCT00463853
Clinical Trials (5)
Showing 5 of 5 trials
NCT01086540Phase 2
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
NCT02948322Not Applicable
Cardiac (CMRI) Assessment of Acromegaly
NCT01399073
Virtual Reality for Neglect Diagnostics
NCT02875730Phase 4
A Pilot Investigation Detecting Cryoablation Scar by 3D Late Gadolinium Enhancement
NCT00463853Phase 1
Stem Cell Therapy as Adjunct to Revascularization
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5